|
|
|
- あつの こやぎ
- 7 years ago
- Views:
Transcription
1
2
3 LD LD LD -2-
4 MBD Minimal Brain Dysfunction Syndrome -3-
5 Minimal Brain Dysfunction Syndrome : --- WISC-WPPSIK-ABC --- CTMRIEEG
6 -5- MBD MBD MBD MBD LD LD
7 -6- LD LD MBD, LD
8 often a b c 1 d e f g h i 2 a b c d e f a b c -7-
9 -8-
10
11 -10-
12
13 -12-
14 -13-
15 -14-
16 CT MRI LD CT -15-
17 -16-
18 -17-
19 -18-
20 LD LD LD -19-
21 LD -20-
22 -21-
23 LD -22-
24 -23- WISC-R WISC-
25 -24-
26 LD LD -25-
2
() () 980-8578 Tel: 022-795-6092 Fax: 022-795-6096 email: 1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 17 46 47 4.1.1
104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26
25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (
釧路市幼児教育振興計画（完成版）.doc
17 18 10 17 20 29 10 15 19 9,762 9,151 611 29 19 1,842 20 19 3,980 2,706 68 100 1,841 90 17 10 89 44 19 3,560 2,563 72 19 () () () 29 3,980 2,706 67.99 26 1,855 1,841 99.25 55 5,835 4,547 77.93 15
スライド 1
1. 2. SST 3. SST 4. SST 5. 6. SST (Caldarella & Merrell,1997) SST 1. 2. 3. 4. 5. 3-1 ABC WISC LD ADHD SST ADHD 3-1 3-2 3-3 3-4 SST 1. 2. ADHD SST ADHD SST 3-5 SST SST ADHD SST 4-1SST 4-2 4-3 4-4
天草郡市医師会第139回(臨時)代議員会
A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (
,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,
1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20
(1-1) 37-1 37-2,3 (37) (52) (57 62) ICD-10 ICF GAF ICD-10 DSM- WAIS-R MMPI BDI P-F CT,MRI,EEG,, CT 2004.10.5 (dynamic) 1 1,2003 Link & Stueve 1994 BPRS15. BPRS12. (BPRS4. ) BPRS7. BPRS11. BPRS8. Hodgings,1999
8 8 0
,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7
ADHD LD ITPA K ABC DSM ADHD LD MBD WISC K ABC ITPA 62
How Can We Understand A Difficult Child From A Clinical Viewpoint The st Report An Analysis of descriptions of children s problem behaviors by teachers in nursery schools Koichi HIGO ADHD LD 61 ADHD LD
肝臓病教室201207v2配布用.pptx
24 7 28 5 C C C C 11 1 vs 2 vs 1 0 1 600-1000mg 3-5/ 24,48 2448 12 1 1500-2250mg 6-9/ () 1 600-1000mg 3-5/ 0 24 88.1% 0 20 40 60 80 100 C ALT, GPT 30 34.4% ALT, GPT 0 20 40 60 80 100 2 , 2 3 1 1-100% 0
untitled
25 13 50 15.2%6,262 誹 10 13 14 15 18 19 21 21 22 24 27 30 31 32 34 36 50 e 51 25 10 10 15 265 136 401-1- -2- 25 25 13 45,525 59 43,531 90.7 10 1,994 39.6 69 45,525 88.5-3- -4- -5- -6- -7- -8- 誹 誹 誹 -9-
1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%
untitled
* * ** ** ** * ** -1- -2-16 10 23 65 17 17 30 83.1 54 1 2 3 1 4 1 80 20 91-3- 2 76 96 3-4- 12 11 10-5- -6- 1 2-7- 3 4 11-8- 67-9- LDADHD LD,2004 ADHD,2004,2004 1 10 2 11-10- 1 2-11- 17 3 4 2004 http://www.mext.go.jp/b_menu/houdou/16/01/04013002.htm
A 01 2 015 10 11 12 G 011 2 0111 67
66 A 01 2 015 10 11 12 G 011 2 0111 67 0119 0112 0113 68 0130 0128 0114 0113 0115 0116 0119 69 0111 0128 012 2 0121 1102 0122 0123 0124 70 0125 0126 0126 0111 0127 71 0128 0129 0230 013 0130 0130 011 012
遺産センター2009年報
20 10 20 21 400 20 2218 22 34 22 12 1 .......................................................................................... 4.............................................................................................
2 2 TEL.03-5286-1681 http://www.adic.rise.waseda.ac.jp/adic/index.html FAX FAX03-3255-5115 e-mail : gyoki@sonpo.or.jp TEL.03-5286-1681 http://www.adic.rise.waseda.ac.jp/adic/index.html FAX FAX03-3255-5115
untitled
LD,ADHD, 1 ADHD 2 1010100 100 LD (WISC-) Learning disabilities Learning disorders ADHD Attention-Deficit/Hyperactivity Disorder http://www.mext.go.jp/b_menu/s hingi/chousa/shotou/018/toushin/ 030301i.htm
(1) 3 (2) 4 (3) (1) 8 () 8 ()] (2) 11 () () 13 () () (1) 16 () 16 () 16 () 19 (
![(1) 3 (2) 4 (3) (1) 8 () 8 ()] (2) 11 () () 13 () () (1) 16 () 16 () 16 () 19 (](/thumbs/49/25497123.jpg "(1) 3 (2) 4 (3) (1) 8 () 8 ()] (2) 11 () () 13 () () (1) 16 () 16 () 16 () 19 (")
ISSN1344221X 1. 2 2. 3 (1) 3 (2) 4 (3)19 7 3. 8 (1) 8 () 8 ()] 10 10 11 (2) 11 () 11 11 12 () 13 () 13 3 4 13 14 14 () 14 14 14 14 4. 16 (1) 16 () 16 () 16 () 19 () 19 () 21 () 22 (2) 36 () 36 () 36 (3)
2 / 20
2 / 20 3 1 4050 5 3 / 20 4 / 20 5 / 20 6 / 20 11 7 / 20 3 14:0016:00 03-3325-9275 8 / 20 9 / 20 10 / 20 11 / 20 FAX: 03-6666-8560 E-mail: okomarisan@creosore.or.jp 12 / 20 13 / 20 (1) (2) (3) (4) (5) (6)
NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml
NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008
1. 2 2. 3 (1) 3 (2) 4 (3) 20 7 3. 8 (1) 8 () 8 ()] 10 10 11 (2) 11 () 11 11 11 () 11 11 11 () 12 3 4 12 12 12 () 12 12 13 13 4. 14 (1) 14 () 14 () 14
![1. 2 2. 3 (1) 3 (2) 4 (3) 20 7 3. 8 (1) 8 () 8 ()] 10 10 11 (2) 11 () 11 11 11 () 11 11 11 () 12 3 4 12 12 12 () 12 12 13 13 4. 14 (1) 14 () 14 () 14](/thumbs/41/22558859.jpg "1. 2 2. 3 (1) 3 (2) 4 (3) 20 7 3. 8 (1) 8 () 8 ()] 10 10 11 (2) 11 () 11 11 11 () 11 11 11 () 12 3 4 12 12 12 () 12 12 13 13 4. 14 (1) 14 () 14 () 14")
ISSN1344 221X 1. 2 2. 3 (1) 3 (2) 4 (3) 20 7 3. 8 (1) 8 () 8 ()] 10 10 11 (2) 11 () 11 11 11 () 11 11 11 () 12 3 4 12 12 12 () 12 12 13 13 4. 14 (1) 14 () 14 () 14 () 14 () 15 () 15 () 15 (2) 29 () 29
Digital Photo Professional Ver1.6（Windows）
Windows CT1-5193-000 CANON INC. 2005 J 1 2 3 4 s s s 1 1 s s s s s 1 1 a s s 1 s s 1 2 s a 1 s a 2 3 1 1 s a a 2 a 3 a s s 1 a a s a s s 1 s s 1 2 3 s 1 1 a 2 a 1 a s 2 3 1 1 s a 2 1 3 1 s a 2
がん診療におけるFDG FDG-PET/CTの役割
PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT
untitled
16 17 1 8 15 () () 17 1 1 1. ---------------------------------------------------------------------- 2 2. ----------------------------------------------------------- 11 3. -------------------------------------------------
100
100 http://www.nomura.co.jp/retail/bond/beginner_bond/index.html 10 25 10 5 3 10 5 2 2 11 22100 100 (1 )( 100 1 1 1 1.5 1 2 100 ) 10020.51 100100 12 1002 22100 99 (2 1 )( 99 1 1 1 1.5 1 1 ) 10020.51
17 18 3 13 5 13 2 1773 2 3 154 742 424 318 2 8 1695 10 16 1883 3 4 1821 5 3 6 6 3 4 5 7 1770 1 3 200 3 1753 6 3 7 200100 2 7 46 11 179912 1,750 5 1822 6 5 30 2 1861 100 11 538 5 4 6 100 3 1803 5 3 1753
provider_020524_2.PDF
1 1 1 2 2 3 (1) 3 (2) 4 (3) 6 7 7 (1) 8 (2) 21 26 27 27 27 28 31 32 32 36 1 1 2 2 (1) 3 3 4 45 (2) 6 7 5 (3) 6 7 8 (1) ii iii iv 8 * 9 10 11 9 12 10 13 14 15 11 16 17 12 13 18 19 20 (2) 14 21 22 23 24
untitled
2008 6 No.3 2008 6 3. 2008 4 168-0064 4-19-4 2-C Tel.: 03-3327-9225 FAX: 03-6666-8560 E-mail: sgnm151@mx2.ttcn.ne.jp 1 / 16 2008 6 No.3 2 / 16 2008 6 No.3 3 / 16 2008 6 No.3 1213 4 / 16 2008 6 No.3 5 /
kennsetusuijyunnakabane.xls
75 50 35 25 20 12 8 6 1/10 1/9 1/8 1/7 1/6 1/5 1/4 1/3 1,200 1,200 1,500 1,800 (1,100) (1,100) (1,450) 850 1,200 1,500 1,800 (800) (1,100) (1,450) 850 (800) 850 (800) 850 (800) 1,800 1 850 2 3 41 db AA
Taro13-04.ガイドライン【１部～
1 2 3 4 , 11 5 6 A 4.5 B 2.5 3.3 0.9 1.2 0.1 0.2 0.3 0.2 C 0.8 7 8 12 14 83 84,, 9 LDADHD LDADHD, 10 11 12 http://www.mext.go.jp/a_menu/shotou/tokubetu/f_03110701.htm 13 4 14 15 16 17 18 19 1 2 20 21 22
県委託研究
55 15 7 21 55 2,500 651-0073 1 5 2 6 ( ) 21 0782 625 578 E-Mail: murakami@21human.jp 15 7 1 7 31 () 1. 10 2.
2
1 2 3 1) 2) 3) 2 3 1 2 3 4 5 6 7 8 9 10 11 4 12 13 14 15 X 16 X 17 X CT 18 MRI 19 20 4 A. ENG T&T B. ABLB SISI ABR ASSRMLRSRL 5 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 1 2 3 4 7 1 POS( Problem
Ⅱ 防災計画の概要
12 ( 10 304 3 16 14 25 3 ) ( ) 1 3 1 18 12 2 ( ) ( ) 18 12 ( ) ( ( ) ( ) ( ) ( ) 1 ( ) 3 ( ) ( ) ( ) 4 5 1 2 3 ( ) 4 1 1 6 7 3 3 2 3 3 ( ) 1 AM PM 8 9 8 30 8 50 8 50 9 00 9 00 9 50 10 00 11 00 11 00 12
20●12頁●６－１４▲放射線科▲.ppt
No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%
10K1A NASA () SPACE ATLAS Freedom H2A NASA 1
10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C
S22 vol. 38 Suppl. 2013 38-3-2 38-3-3 38-3-4 38-3-5 JA 4 6 15 14:35 15:15 3 38-4-1 1 JA 38-4-2 10 38-4-3 38-4-4 5 5 6 15 15:20 16:10 3 38-5-1 1 38-5-2
vol. 38 Suppl. 2013 S21 1 6 15 11:25 12:15 4 38-1-1 38-1-2 US 38-1-3 1 38-1-4 38-1-5 2 6 15 13:40 14:30 3 38-2-1 1 38-2-2 38-2-3 CHI-Q 38-2-4 1 38-2-5 IgG4 3 6 15 13:40 14:30 4 38-3-1 S22 vol. 38 Suppl.
10県別セミ-01.ai
2010 4 Point 1 K O 2 Point 2 Point 3 3 4 4/25 4/2 4/2 4/25 25 25 4/2 4/25 25 1 / 1 /2 25 25 2 J 1 / 1 / 25 25 J 5/2 5/2 5/29 29 29 5/2 5/29 29 30 30 30 30 30 30 J 6/14 18 J 6/14 18 J 7/26 30 7/27 30 J
1 2 3 5 つ の な 4 24 5 H27 H28 H29 H30 H31 H32 1 2 6 7 2 3 6 22.3 1.3 1.7 1.6 7 8 9 10 73.6 86.4 70.4 79.6 11 12 ( ) 25 2 2 10 2 10 2 13 14 15 16 17 18 25 25 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
kaihou38-1
060-0001 2012 38 4 10 TEL 011-233-5130 FAX 011-233-5135 E-mail hk-higaisha@nifty.com http://homepage2.nifty.com/ hk-higaisha/ 23-1 - - 2 - - 3 - - 4 - 2012 38-5 - 2012 38 14 1 3 10-6 - 2012/04/10 No.38-7
NEDO
10 MRI 1 1 595% 5 IOR 100% MRI MRI MRI MRI MRI MRI 11 MRI 3 2 1 MRI 1 1.5 0.000005 100 5 MRI MRI MRI MRI MRI MRI MRI MRI MRI (1) MRI MRI 0.3 3 MRI 1 / (2) MRI MRI (3)MRI MRI 3 (4)MRI MRI MRI (5)MRI 2006
1
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 E-mail: support@systems.citizen.co.jp http://www.citizen-systems.co.jp
1 2000 2 ITC 1 10 4 23 2007 3 2005 ) ---------------------------------------------------------------------------------------------------------------------------------------
2
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 http://www.kairen.co.jp/japanese/download/dl.technote.html 19 20 Tegakitous http://www.kairen.co.jp/japanese/technote/ 359-1115 11-1 TEL: 04-2928-6836 FAX: 04-2929-6297
2010 5 No.20 2 / 32
2010 5 No.20 2 / 32 2010 5 No.20 3 / 32 2010 5 No.20 4 / 32 2010 5 No.20 5 / 32 2010 5 No.20 6 / 32 2010 5 No.20 7 / 32 2010 5 No.20 8 / 32 2010 5 No.20 9 / 32 2010 5 No.20 10 / 32 2010 5 No.20 11 / 32
2
MATUNO 2 3 4 1 3 5 3C 13:00 14:00 15:30 18:00 9:00 10:00 10:20 10:50 12:00 6 13:00 14:00 15:30 18:00 9:00 10:00 10:20 10:50 12:00 7 8 9 19:00 13:00 16:00 18:00 9:00 10:00 10:20 10:50 12:00 10 19:00 13:00
第４８期 決算説明会
04/9 04/11 05/1 05/3 05/5 05/7 (7/6 ),... 4.1% 8.4% 60.4% 27.1% 173 183 173 183 0% 5% 10% 15%. %. % 173 % 1,000 287 170% 9 % :http//www.maezawa-k.co.jp E-mail : keikan@maezawa-k.co.jp
-2-
Super Lizer HT-2200 m m W Super Lizer -1- -2- -3- -4- stellate ganglion block stellate ganglion -5- -6- -7- -8- IgA -9- " " -10- -11- 5 6 10 1-12- -1- -2- mv -3- -4- -5- -1- : -2- No.2576 P.25 1973-3-
橡アロマセラピー症状別処方例.PDF
1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20
X FRT.qxp
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 http://www.microsoft.com/japan/security/ http://www.symantec.co.jp/ http://www.symantec.co.jp/region/jp/techsupp/index.html http://www.symantec.co.jp/region/jp/sarcj/index.html
untitled
19 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15 19 19 1 17,676 20.0 2 20,970 24.1 3 4,967 23.2 104,10919 4 8,234 18.0 11,428 22.4 1 0 10,954244 17,107 18.7 136 4.8 12,653205 1,239 13.2 10,056686 27,305514
